EGFR and non-small cell lung carcinoma: In the overall population, the median OS was 37.5 months (95% CI: 35.4–39.6) and 25.6 months (95% CI: 18.2–33.0) for common EGFR mutation-positive NSCLC and uncommon EGFR mutation-positive NSCLC, respectively (Figure S1B) (p < 0.001).